Dr. Ashraf Dallol: Harness NGS Technology to Precision Medicine at NoorDx

Поделиться
HTML-код
  • Опубликовано: 12 сен 2024
  • Dr. Ashraf Dallol, PhD in Biomedical Science from the University of Ulster and Chief Scientific Director at NoorDx, provided an in-depth look at the use of Next-Generation Sequencing (NGS) technology in advancing #genomics research and clinical applications. He underscored the instrumental role of #MGI sequencers in powering NoorDx's research initiatives.
    Dr. Dallol is optimistic about a future where #NGS technology is further applied to deliver cost-effective, accurate and reliable clinical reports, ultimately benefiting more patients.
    #saudiarabia #FutureofOmicsResearchSummit

Комментарии •